Pregabalin dependence with pregabalin induced intentional self-harm behavior: A case report.

The article presents a case report on the pregabalin dependence with pregabalin induced intentional self-harm behavior. It provides information on pregabalin as a novel gamma amino butyric acid (GABA) analogue used for neuropathic pain and partial onset seizures. It notes that the U.S. Food and Drug Administration has categorized pregabalin as a schedule V drug under the terms of controlled substances act.